stock ticker for SNDL

Updates:

Monday, March 01 2021 9:09 AM, EST


Cannabis and Psychedelics are Booming: CEOs of Sundial Growers, Icanic Brands, OrganiGram, and Delic Holdings Are Ready

GlobeNewswire   “Press Releases”

NEW YORK, March 01, 2021 (GLOBE NEWSWIRE) — Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: OrganiGram Holdings (NASDAQ: OGI) Icanic Brands (OTC: ICNAF) Delic Holdings (CSE: DELC) (OTC: DELCF) Sundial Growers (NASDAQ: SNDL).

New legalized market opportunities for cannabis and psychedelics are expanding globally – creating massive revenue growth opportunities. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Sundial Growers (NASDAQ: SNDL), CEO Zach George: Evolving to Deliver Higher THC Potency Meeting New Consumer Demands

…Canadian cannabis consumer preferences are evolving, but are currently biased towards high THC potency. We have had to rapidly adapt our cultivation processes to meet those demands over the last six months….the modular nature of our facility provides Sundial the ability to rapidly adapt to evolving market conditions and we continue to be agile in our response. The scale and modular room design of Sundial’s cultivation facility make it one of the best in Canada. Since inception, we’ve compiled a broad spectrum of cultivation statistics, including more than 600 harvests, including 243 in 2020 and 52 in the third quarter alone. Sundial has leveraged his data analytics capabilities to focus on key improvement areas. I am proud to say that just last month in October we generated the highest average potency results since Sundial’s inception

…To continue to serve evolving consumer preferences Sundial has also acquired an expanded library of genetics. We expect these genetics to have a financial impact in early 2021. …We exited Q3 with lower costs, greater efficiencies and dramatic improvements to our balance sheet. Despite underperforming on revenue, we reached several key operating milestones. As we continue to improve our processes, we are also working to elevate our customer experience while driving long-term growth

Sundial Growers, Inc. (NASDAQ: SNDL) Q3 2020 Earnings Highlights: https://bit.ly/3oFJgO7

Wednesday, February 24 2021 7:54 AM, EST


SUNDIAL AND INDIVA ANNOUNCE CLOSING OF $22 MILLION STRATEGIC INVESTMENT

M2 Communications   “ENP Newswire”

Sundial Growers Inc. (‘Sundial’) (NASDAQ: SNDL), a Canadian licensed producer of recreational cannabis and Indiva Limited (‘Indiva’) (TSXV: NDVA) (OTCQX: NDVAF), a leading Canadian producer of cannabis edibles, are pleased to announce the closing of the previously announced $22,000,000 strategic investment (the ‘Investment’) into Indiva by Sundial.

The Investment was completed by way of a brokered private placement (the ‘Placement’) led by ATB Capital Markets Inc. (‘ATB’ or the ‘Agent’) of 25,000,000 common shares of Indiva (the ‘Common Shares’) at a price of $0.44 per Common Share, raising gross proceeds of $11,000,000 (the ‘Equity Investment’), and a secured non-revolving term loan facility to Indiva in the principal amount of $11,000,000 (the ‘Term Loan’). Sundial was the sole subscriber in the Placement and sole lender of the Term Loan. The Term Loan matures on February 23, 2024 (the ‘Maturity Date’) and bears an interest rate of 9% per annum. 50% of accrued interest is payable in cash on the last day of each month and the remaining 50% of accrued interest is payable, at the option of Indiva, (i) in cash on the last day of each month, or (ii) payable in arrears on the Maturity Date. The Term Loan was issued at an original issue discount of 4% and provides that upon a change of control of Indiva, Sundial shall have the option exercisable within 60 days to require Indiva to prepay 104% of the outstanding principal amount of the Term Loan and all accrued and unpaid interest. Pursuant to the Investment, Sundial and Indiva entered into an investor rights agreement (the ‘IRA’) whereby Sundial was granted the right to participate in future equity financings to maintain its pro-rata ownership in Indiva and registration rights, subject to customary limits and exceptions. In addition, the IRA provides that in the event Indiva completes a further offering of securities, which contain warrants, in the ninety (90) days following the closing of the Investment (a ‘Further Offering’), it shall issue to Sundial, for no additional consideration, and on the terms of such warrants offered in the Further Offering, such number of warrants equal to the number of warrants Sundial would have received had the Equity Investment been made in the Further Offering (the ‘Conditional Warrants’). Any issuance of Conditional Warrants is subject to the prior approval of the TSX Venture Exchange (the ‘TSXV’) and if issued, will contain a provision preventing their exercise if, following such exercise, Sundial or its affiliates would hold greater than 19.9% of the issued and outstanding Common Shares and have a maximum term of five (5) years. Indiva intends to use the net proceeds of the Investment to retire its outstanding debt in full, which includes its demand loan and promissory note, as well as for working capital and other general corporate purposes. The Investment is subject to the final approval of the TSXV. The Common Shares issued under the Placement will be subject to a statutory hold period of four months and one day following the closing of the Placement. Pursuant to the Investment, Indiva paid to ATB: (a) a cash commission equal to $330,000 being 3.0% of the aggregate gross proceeds from the Placement and (b) a financial advisory fee of $220,000, being 2.0% of the principal amount of the Term Loan.

Friday, February 19 2021 9:02 AM, EST


Sundial Announces Issuance of New Warrants and US$89.1 Million Proceeds from Warrant Exercises

Canada Newswire   “Canada Newswire English”

CALGARY, AB, Feb. 19, 2021 /CNW/ -Sundial Growers Inc. (NASDAQ: SNDL) (“Sundial” or the “Company”) announced today that holders (the “Holders”) of 98,333,334 warrants (the “Warrants”) to purchase common shares (the “Common Shares”) of the Company will exercise for cash their Warrants at prices of US$0.80 and US$1.10 for gross proceeds to Sundial of US$89.1 million.

In exchange, the Company will issue 98,333,334 warrants (the “New Warrants”), each entitling the Holders to purchase one Common Share at an exercise price of US$1.50, subject to customary anti-dilution adjustments. Sundial has granted the Holders rights to have the Common Shares issuable upon exercise of the New Warrants registered pursuant to a registration statement (the “Registration Statement”) to be filed with the SEC. The New Warrants are immediately exercisable and have a term of 42 months from the effective date of the Registration Statement.

Wednesday, February 17 2021 7:00 AM, EST


Sundial Regains Compliance with Nasdaq Minimum Bid Price Rule

Canada Newswire   “Canada Newswire English”

CALGARY, AB, Feb. 17, 2021 /CNW/ -Sundial Growers Inc. (NASDAQ: SNDL) (“Sundial” or the “Company”) today announced that the Nasdaq Stock Market (“Nasdaq”) has confirmed that the Company has regained compliance with Nasdaq’s minimum bid price requirements for continued listing on the Nasdaq Capital Market.

As a result of the closing bid price of the Sundial’s common shares

 

 

 having been at US$1.00 per share or greater for at least ten consecutive business days, the Company has regained compliance with Nasdaq’s Listing Rule, and the matter is now closed.

About Sundial Growers Inc.

Sundial is a public company with Common Shares traded on Nasdaq under the symbol

Tuesday, February 16 2021 8:30 AM, EST


Sundial and Indiva Announce $22 Million Strategic Investment

PR Newswire   “Press Releases US – English”

BROKERED PRIVATE PLACEMENT OFFERING OF $11,000,000 IN COMMON SHARES PLUS $11,000,000 TERM LOAN FACILITY

CALGARY, ABandLONDON, ON, Feb. 16, 2021 /PRNewswire/ -Sundial Growers Inc. (“Sundial“) (NASDAQ: SNDL), a Canadianlicensed producerof recreationalcannabis and Indiva Limited (“Indiva“) (TSXV: NDVA) (OTCQX: NDVAF), a leading Canadian producer of cannabis edibles, are pleased to announce a $22,000,000 strategic investment (the “Investment”) into Indiva by Sundial.

The Investment will be completed in the form of a brokered private placement (the “Placement“) led by ATB Capital Markets Inc. (“ATB” or the “Agent“) of 25,000,000 common shares of Indiva (the “Common Shares“) at a price of $0.44 per Common Share, to raise gross proceeds of $11,000,000, and a non-revolving term loan facility to Indiva in the principal amount of $11,000,000 (the “Term Loan“). It is anticipated that Sundial will be the sole subscriber in the Placement. Proceeds to Indiva, net of fees, commissions and expenses are expected to be approximately $20.9 million.

“Sundial is pleased to support the development of Indiva’s high-quality products,” said Zach George, Chief Executive Officer of Sundial. “This transaction broadens our exposure to the rapidly expanding cannabis edibles category.”

Indiva intends to use the net proceeds of the Placement and Term Loan to retire its outstanding debt in full, which includes its demand loan and promissory note, as well as for working capital and other general corporate purposes.

“We are delighted to welcome Sundial as a strategic investor in Indiva,” said Niel Marotta, President and Chief Executive Officer of Indiva. “The capital from this $22 million investment significantly improves Indiva’s balance sheet, expands our working capital, and provides the resources necessary to support strong growth in our business. Indiva will now have the ability to make additional capital investments, primarily into automation, which will drive higher throughput and profitability, while ensuring our product quality maintains the best-in-class standard our customers and clients depend upon. Indiva’s bolstered financial strength will ensure we can defend our market share position as a top edibles producer in Canada, and continue to bring new and innovative cannabis products to of-age Canadians.”

Sundial and Indiva intend to complete the Investment on or about February 23, 2021, subject to certain conditions customary for transactions of this nature, including, but not limited to, the receipt of all necessary approvals, including the approval of the TSX Venture Exchange.

The securities issued under the Placement will be subject to a statutory hold period of four months and one day following the closing of the Placement.

Indiva has agreed to: (a) pay to ATB a cash commission equal to 3.0% of the aggregate gross proceeds received by Indiva from the Placement from Sundial and 6.0% of the aggregate gross proceeds received by Indiva from the Placement from subscribers other than Sundial, if applicable; and (b) pay to the Agent a cash commission equal to 2.0% of the total loan commitment under the Term Loan.

Sundial and Indiva Announce $22 Million Strategic Investment

GlobeNewswire   “Press Releases – Canada”

CALGARY, Alberta and LONDON, Ontario, Feb. 16, 2021 (GLOBE NEWSWIRE) — Sundial Growers Inc. (“Sundial“) (NASDAQ: SNDL), a Canadianlicensed producerof recreationalcannabis and Indiva Limited (Indiva) (TSXV:NDVA) (OTCQX:NDVAF), a leading Canadian producer of cannabis edibles, are pleased to announce a $22,000,000 strategic investment (the Investment) into Indiva by Sundial.

The Investment will be completed in the form of a brokered private placement (the “Placement“) led by ATB Capital Markets Inc. (“ATB” or the Agent) of 25,000,000 common shares of Indiva (the “Common Shares“) at a price of $0.44 per Common Share, to raise gross proceeds of $11,000,000, and a non-revolving term loan facility to Indiva in the principal amount of $11,000,000 (the “Term Loan“). It is anticipated that Sundial will be the sole subscriber in the Placement. Proceeds to Indiva, net of fees, commissions and expenses are expected to be approximately $20.9 million.

Sundial is pleased to support the development of Indivas high-quality products, said Zach George, Chief Executive Officer of Sundial. This transaction broadens our exposure to the rapidly expanding cannabis edibles category.

Indiva intends to use the net proceeds of the Placement and Term Loan to retire its outstanding debt in full, which includes its demand loan and promissory note, as well as for working capital and other general corporate purposes.

We are delighted to welcome Sundial as a strategic investor in Indiva, said Niel Marotta, President and Chief Executive Officer of Indiva. The capital from this $22 million investment significantly improves Indivas balance sheet, expands our working capital, and provides the resources necessary to support strong growth in our business. Indiva will now have the ability to make additional capital investments, primarily into automation, which will drive higher throughput and profitability, while ensuring our product quality maintains the best-in-class standard our customers and clients depend upon. Indivas bolstered financial strength will ensure we can defend our market share position as a top edibles producer in Canada, and continue to bring new and innovative cannabis products to of-age Canadians.

Sundial and Indiva intend to complete the Investment on or about February 23, 2021, subject to certain conditions customary for transactions of this nature, including, but not limited to, the receipt of all necessary approvals, including the approval of the TSX Venture Exchange.

The securities issued under the Placement will be subject to a statutory hold period of four months and one day following the closing of the Placement.

Indiva has agreed to: (a) pay to ATB a cash commission equal to 3.0% of the aggregate gross proceeds received by Indiva from the Placement from Sundial and 6.0% of the aggregate gross proceeds received by Indiva from the Placement from subscribers other than Sundial, if applicable; and (b) pay to the Agent a cash commission equal to 2.0% of the total loan commitment under the Term Loan.

Tuesday, February 09 2021 9:30 AM, EST


CEOs of OrganiGram, Icanic Brands, Red Light Holland, and Sundial Growers, Driving New Growth Opportunities in Cannabis and Psychedelics

GlobeNewswire   “Press Releases”

NEW YORK, Feb. 09, 2021 (GLOBE NEWSWIRE) — Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: OrganiGram Holdings (NASDAQ: OGI), Icanic Brands (OTC: ICNAF) (CSE: ICAN), Red Light Holland (OTC: TRUFF) (CSE: TRIP), Sundial Growers (NASDAQ: SNDL).

Sundial Growers (NASDAQ: SNDL), CEO Zach George: Evolving to Deliver Higher THC Potency Meeting New Consumer Demands

Canadian cannabis consumer preferences are evolving, but are currently biased towards high THC potency. We have had to rapidly adapt our cultivation processes to meet those demands over the last six months….the modular nature of our facility provides Sundial the ability to rapidly adapt to evolving market conditions and we continue to be agile in our response. The scale and modular room design of Sundial’s cultivation facility make it one of the best in Canada. Since inception, we’ve compiled a broad spectrum of cultivation statistics, including more than 600 harvests, including 243 in 2020 and 52 in the third quarter alone. Sundial has leveraged his data analytics capabilities to focus on key improvement areas. I am proud to say that just last month in October we generated the highest average potency results since Sundial’s inception

…To continue to serve evolving consumer preferences Sundial has also acquired an expanded library of genetics. We expect these genetics to have a financial impact in early 2021. …We exited Q3 with lower costs, greater efficiencies and dramatic improvements to our balance sheet. Despite underperforming on revenue, we reached several key operating milestones. As we continue to improve our processes, we are also working to elevate our customer experience while driving long-term growth

Sundial Growers, Inc. (NASDAQ: SNDL) Q3 2020 Earnings Highlights: https://bit.ly/3oFJgO7

9 FEB 2021: https://investorplace.com/2021/02/wait-on-sndl-stock-as-it-simply-isnt-priced-to-buy-right-now/

9 FEB 2021: https://www.fool.com/investing/2021/02/09/sundial-growers-the-209-gain-no-one-saw-coming/

6 FEB 2021, Virginia Lawmakers Pass Marijuana Legalization Bills: https://www.rollingstone.com/culture/culture-news/virginia-legalize-marijuana-1124749/amp/

PRNews, 5 FEB 2021: https://www.prnewswire.com/news-releases/as-additional-us-states-move-towards-legalization-the-cannabis-industry-revenues-continue-to-explode-301222886.html

Form 6-K, 3 FEB 2021:  http://archive.fast-edgar.com/20210203/AF2LM22CZM2RS2ZZ272Q2MYQR3GDZZ22Z232/

Form 6-K, 2 FEB 2021: http://archive.fast-edgar.com/20210202/AFZ2M22CZ22BR2Z2222Q2CZZR3GDSZQS4232/

Form 424B5, 2 FEB 2021: http://archive.fast-edgar.com/20210202/AJ22D22CZM2RQ2ZK222Q2WYJN8VEEZ22Z232/

[wp-rss-aggregator feeds=”sndl”]

SNDL – Sundial Growers News – $SNDL

Best day trading stocks under $5? SNDL, $SNDL post is updated with news and tweets as it comes out. Make a better decision before trading.

Friday, January 29 2021 6:37 AM, EST Sundial Growers Announces US$100 Million Registered Offering Canada Newswire   “Canada Newswire English” CALGARY, AB , Jan. 29, 2021 /CNW/ – Sundial Growers Inc. (Nasdaq: SNDL) (“Sundial” or the “Company”) announced today that it has priced a best efforts underwritten registered offering of 100,000,000 Series A Units, each consisting of one common share and one-half Series A Warrant to purchase one common share and 33,333,334 Series B Units (and together with the Series B Units, the “Units”), each consisting of one pre-funded Series B Warrant (together with the Series A Warrants, the “Warrants”) to purchase one common share and one-half Series A Warrant to purchase one common share. Each Series A Unit will be sold at a price of US$0.75 per Series A Unit and each Series B Unit will be sold at a price of US$0.75 per Series B Unit, minus US$0.0001 , and the remaining exercise price of each Series B Warrant will equal US$0.0001 per common share. Sundial’s gross proceeds from this offering are expected to be approximately US$100 million , before deducting underwriting discounts and estimated offering expenses. All of the securities in the offering are being sold by Sundial. The Warrants will be exercisable immediately after issuance and have a term of five years commencing on the date of issuance. The exercise price of the Series A Warrants will be US$0.80 per common share. The offering is expected to close on February 2, 2021 , subject to customary closing conditions.

The Company intends to use the net proceeds from the offering for the financing of possible acquisitions of, or investments in, equipment, facilities, assets, equity or debt of other businesses, products or technologies and for working capital and general corporate purposes.

Canaccord Genuity LLC is acting as sole book-running manager for the offering. A.G.P./ Alliance Global Partners and ATB Capital Markets Inc. are acting as co-managers for the offering.

The offering will be made only by means of a prospectus supplement and an accompanying prospectus filed as part of an effective shelf registration statement filed with the Securities and Exchange Commission (the “SEC”) on Form F-3 and declared effective on January 25, 2021 . A prospectus supplement for the offering will be filed with the SEC and available on the SEC’s website, www.sec.gov. Copies of the prospectus supplement, when available, may be obtained from Canaccord Genuity LLC , Attention: Syndicate Department , 99 High Street , 12th Floor, Boston, MA 02110, or by email at [email protected] This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Form 424B5 Sundial Growers Inc. http://archive.fast-edgar.com/20210129/AJ22D22CZM2RQTZ2222Q2ZYKN8VEEZ22D232/

ABOUT SUNDIAL GROWERS INC.

Sundial is a public company with Common Shares traded on Nasdaq under the symbol “SNDL”.

Sundial is a licensed producer that crafts cannabis using state-of-the-art indoor facilities. Our ‘craft-at-scale’ modular growing approach, award-winning genetics and experienced master growers set us apart.

Our Canadian operations cultivate small-batch cannabis using an individualized “room” approach, with 448,000 square feet of total space.

Sundial’s brand portfolio includesTopLeaf, SundialCannabis, Palmetto and Grasslands. Our consumer-packaged goods experienceenables us to not just growquality cannabis, but alsotocreate exceptional consumer and customer experiences.

We are proudly Albertan, headquartered in Calgary, AB , with operations inOlds, AB, and Rocky View County, AB .

Forward-Looking Information Cautionary Statement This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”), including, but not limited to, statements regarding the Company’s operational goals, demand for the Company’s products and development of the legal cannabis market. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “likely”, “outlook”, “forecast”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements aremade andare subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Please see the risk factors identified in the Company’s filings with the U.S. Securities and Exchange Commission , including those identified in the Company’s Annual Report on Form 20-F, for a discussion of the material risks that could cause actual results to differ materially from the forward-looking information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Friday, February 05 2021 9:00 AM, EST


As Additional U.S. States Move Towards Legalization the Cannabis Industry Revenues Continue to Explode

PR Newswire   “Press Releases US – English”

PALM BEACH, Fla., Feb. 5, 2021 /PRNewswire/ –It seems as if every report on the future growth of revenues in the legal cannabis markets, recreational & medical, predict continued substantial growth through the next several years. Growing acceptance and adoption of legal marijuanafor the treatment of chronic diseases like cancer, arthritis, and Alzheimer’s as well as neurological problems such as depression, anxiety, and epilepsy is a key factor driving the market. The increasing legalization of medical cannabis in the region to curb the black market and provide easy access to patients is also expected to spur market growth.A recent report from IMARC, an industry research organization, said that theNorth Americalegalcannabis marketis expected to reach a value US$ 54.6Billionby 2025. A report from Grand View Research had even higher projections, saying that the North America legal marijuana market size, which was valued at USD $30.1 billion in 2019 and $38.3 in 2020 is expected to grow at a compound annual growth rate (CAGR) of 15.5% from 2020 to 2027, reaching revenues of $104.9 Billion in 2027.Active Companies active today in the cannabis related markets include:Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), THC Therapeutics, Inc. (OTCPK: THCT), Aphria Inc.(NASDAQ: APHA) (TSX: APHA), Sundial Growers Inc. (NASDAQ: SNDL), Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI).

The Grand View Report also stated “as the number of U.S. states legalization is increasing, the market is expected to witness lucrative growth over the forecast period. The U.S. is anticipated to be the fastest-growing country in terms of the market in 2019. This is majorly attributed to high product adoption and utilization owing to government approvals Hence, increasing the support of U.S. citizens regarding the use of medical cannabis will fuel the market growth during the forecast period. Increasing investments in R&D are likely to expand the application in the medical field.”

THC Therapeutics, Inc. (OTCPK: THCT) Breaking News: THC Therapeutics, Inc. (THCT), a forward-thinking, publicly-traded technology company, whose mission statement is, “Better Health through the Science of Nature,” is pleased to announce that the company has joined the Las Vegas Medical Marijuana Association (LVMMA) – THCT plans to leverage the diverse membership of dispensary owners, production facilities, cultivators, labs and various companies to further the company’s growth strategy.

As mentioned in our previous press release, the company is moving forward with its financing plans by potentially raising up to $75 million via a Reg A+ offering. Investors that are interested in more information regarding the planned offering may contact the company at the email address below.

Parker Mitchell, the CEO of THC Therapeutics states, “I am excited that THCT is now a member of the LVMMA and is presently attending the meetings and events. We look forward to the opportunities that this association can provide. Through this partnership, and others like it, we will create a foundation for rapid growth.”

In other active company news in the markets this week:

Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, recently announced it has entered into a strategic agreement with MedReleaf Australia (“MedReleaf”). The companies have signed a five-year supply agreement, which provides for MedReleaf to act as the exclusive supplier inAustraliaof Aurora’s MedReleaf, CanniMed and Aurora brands. Products covered by the agreement will be EUGMP certified and include dried flower, oils, and soft gels, as well as future products employing new delivery mechanisms. The agreement does not require or include any capital investment by Aurora.

MedReleaf Australia, in which Aurora holds a 10% ownership stake, is a fully licenced, private company operating in the Australian medical cannabis sector since 2016. MedReleaf and Aurora currently supply products to the Australian medical cannabis system. This agreement will advance that offering and extend availability of high-quality, medical cannabis to patients. MedReleaf is one of the six founding members of the trade association Medicinal Cannabis Industry Australia (MCIA).

Aphria Inc. (NASDAQ: APHA) (TSX: APHA), a leading global cannabis-lifestyle consumer packaged goods company inspiring and empowering the worldwide community to live their best life, recently announced the addition of topicals to its award winning adult-use brandSolei. Known for its occasion-based offerings, ourSoleiTopicals will join a range of other formats currently available, including whole dried flower and pre-rolls, smoke-free oils, oral sprays, soft gels, and vapes.

Solei is the first brand from Aphria’s portfolio to enter the topicals market with its lineup including three of its popular Moments:Unplug(Lavender), Balance(Orange Citrus), Free(Cucumber Mint) andFreeUnscented.SoleiTopicals have been carefully formulated to provide consumers with the highest potency topical currently available in the Canadian market (500mg of cannabinoid per container) and a superior texture comparable to a premium non-infused cream – rich to the touch.

Sundial Growers Inc.(NASDAQ: SNDL) recently announced that it has closed a best efforts underwritten registered offering of 60,500,000 Series A Units, each consisting of one common share and one-half Series A Warrant, with each whole Series A Warrant entitling the holder to purchase one common share, and 14,000,000 Series B Units (and together with the Series B Units, the “Units”), each consisting of one pre-funded Series B Warrant (together with the Series A Warrants, the “Warrants”) to purchase one common share and one-half Series A Warrant, with each whole Series A Warrant entitling the holder to purchase one common share. Each Series A Unit was sold at a price ofUS$1.00per Series A Unit and each Series B Unit was sold at a price ofUS$1.00per Series B Unit, minusUS$0.0001, and the remaining exercise price of each Series B Warrant is equal toUS$0.0001per common share. The Warrants are immediately exercisable and have a term of five years commencing on the date of issuance. Only whole Warrants are exercisable. The exercise price of the Series A Warrants is equal toUS$1.10per common share. All of the securities in the offering are being sold by Sundial.

Organigram Holdings Inc.(NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended November 30, 2020 (“Q1 Fiscal 2021” or “Q1 2021”).

Friday, January 22 2021 8:30 AM, EST


Cannabis Delivery Services Are Becoming One of the Hottest Revenue Streams in Cannabis Market

PR Newswire   “Press Releases US – English”

PALM BEACH, Fla., Jan. 22, 2021 /PRNewswire/ — Revenue projections for the recreational and medical marijuana markets keep rising, each one larger than the previous studies.According to a recentreportby ArcView Market Research and BDS Analytics, the global licensed dispensary sales of cannabis will reach$40.6billion by 2024, registering a CAGR of24.5%. The US will account for about$30billion or73%of the global cannabis dispensing market in 2024. It is also projected that by 2024 the retail dispensing sales of legal recreational cannabis will reach $26.7billion whereas the revenue generated from the sales of medical cannabis will reach$13.9billion but the most, according to an articlein High There says that the delivery sub-market will be the highest , fastest growing stream in the market. They said: “The cannabis industry continues to skyrocket as it’s legalized across the country and other parts of the world. As the industry surges forward, new laws help change how cannabis businesses provide for their customers. Cannabis delivery, for example, is heating up across California for the canna-businesses that took the next big step early and got a delivery license After California legalized statewide cannabis delivery, it removed the previous regulations that prevented the legal access to cannabis delivery across the state.” Active Cannabis companies in the markets this week include NxGen Brands Inc. (OTCPK: NXGB), Sundial Growers Inc.(NASDAQ: SNDL), HEXO Corp (NYSE: HEXO) (TSX: HEXO), Canopy Growth Corporation(NASDAQ: CGC) (TSX: WEED), KushCo Holdings, Inc.(OTCQX: KSHB).

The High There article continued: “States that have already legalized cannabis, like California, are seeing a spike in business thanks to the overwhelming convenience of cannabis delivery being the next wave in cannabis commerce. What many are considering the next trend for cannabis business, delivery services can help surge revenue for the retailers that jump in to take advantage. The cannabis industry is already a recording (all-time highs) and (continues) climbing… A particularly explosive section of this industry is almost exclusively the new cannabis delivery sector.In fact, (in 2016), according to industry reports, 44% of medical marijuana users across the U.S. regularly used a cannabis delivery service to buy their bud. With legalization only having ramped up since then, it’s likely the numbers have only continued to increase, making the market ripe for cannabis delivery.”

Other recent developments in the markets include:

Sundial Growers Inc.(NASDAQ: SNDL) has recently launched high-quality cannabis derivative products under the Top Leaf brand in response to rising consumer demands for solventless cannabis extracts. This most recent launch is consistent with Sundial’s focus on premium inhalables, following branded retail offerings of flower, pre-roll and vape cartridges.

“We made a strategic decision to produce these premium products based on demand for solventless, flavorful, pure, and potent cannabis concentrates from a growing group of consumers,” saidAndrew Stordeur, President and Chief Operating Officer of Sundial. “Our control of the entire manufacturing process from cultivation to extraction enables us to deliver premium quality products on a consistent basis. Adding bubble hash and other advanced concentrates to our product portfolio will expand Sundial’s share of this rapidly expanding market segment.”

View original content:http://www.prnewswire.com/news-releases/cannabis-delivery-services-are-becoming-one-of-the-hottest-revenue-streams-in-cannabis-market-301212932.html

SOURCE Financialnewsmedia.com


View original content to download multimedia:http://www.prnewswire.com/news-releases/sundial-growers-announces-us100-million-registered-offering-301218007.html

Leave a Reply